Literature DB >> 35496967

Clinical Characteristics of Pediatric Patients with Congenital Erythrocytosis: A Single-Center Study.

Sema Aylan Gelen1, Nazan Sarper1, Emine Zengin1, İnci Tahsin1, Mehmet Azizoğlu1.   

Abstract

Although congenital erythrocytosis (CE), an inherited disorder, impairs pediatric quality of life, physicians often overlook high hemoglobin (Hgb) levels and its symptoms due to lack of knowledge of age-adjusted pediatric Hgb levels and CE's rarity. In a retrospective, single-center study, data from hospital records of pediatric patients diagnosed with CE were evaluated. Twenty-six patients from 25 families (80.8% male) had been diagnosed with CE in 20 years, at a mean age of 14.9 ± 2.8 years (8.3-17.8) and with a mean Hgb level of 17.36 ± 1.44 g/dL (14.63-22.1). No serum erythropoietin levels exceeded the reference levels. Although the most common symptom was headache (85%), 38% of patients presented with at least one gastrointestinal symptom (e.g., nausea, vomiting, abdominal pain, and rectal bleeding), and 54% exhibited plethora. No patient had leukocytosis, thrombocytosis, JAK2 mutation; capillary oxygen saturation, venous blood gas analysis, and Hgb electrophoresis revealed no abnormalities. While 34.6% of patients had family histories of CE, 42.3% had 15-45-year-old relatives who had experienced myocardial infarction, stroke, and/or sudden death. Aspirin was routinely prescribed, and phlebotomy was performed when hyperviscosity symptoms were present. To detect CE, physicians should consider age-adjusted normal Hgb levels in children. Pediatric patients with CE may also present with gastrointestinal symptoms. Although no thrombotic episode occurred among the patients, their family histories included life-threatening thrombotic episodes, even in adolescents. © Indian Society of Hematology and Blood Transfusion 2021.

Entities:  

Keywords:  Childhood; Congenital erythrocytosis; Gastrointestinal symptoms; Polycythemia

Year:  2021        PMID: 35496967      PMCID: PMC9001768          DOI: 10.1007/s12288-021-01484-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  23 in total

1.  An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia.

Authors:  Peter L Johansson; Soodabeh Safai-Kutti; Jack Kutti
Journal:  Br J Haematol       Date:  2005-06       Impact factor: 6.998

Review 2.  Congenital erythrocytosis.

Authors:  M F McMullin
Journal:  Int J Lab Hematol       Date:  2016-05-09       Impact factor: 2.877

3.  Thrombotic and hemorrhagic complications in idiopathic erythrocytosis.

Authors:  Irene Bertozzi; Marco Ruggeri; Ilaria Nichele; Giacomo Biagetti; Elisabetta Cosi; Maria Luigia Randi
Journal:  Am J Hematol       Date:  2017-08-17       Impact factor: 10.047

4.  Genetic heterogeneity of primary familial and congenital polycythemia.

Authors:  R Kralovics; J T Prchal
Journal:  Am J Hematol       Date:  2001-10       Impact factor: 10.047

5.  Percentile curves for hemoglobin and red cell volume in infancy and childhood.

Authors:  P R Dallman; M A Siimes
Journal:  J Pediatr       Date:  1979-01       Impact factor: 4.406

6.  Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.

Authors:  Eric Bachman; Thomas G Travison; Shehzad Basaria; Maithili N Davda; Wen Guo; Michelle Li; John Connor Westfall; Harold Bae; Victor Gordeuk; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-24       Impact factor: 6.053

7.  Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (Where is/are the missing gene(s)?).

Authors:  Celeste Bento; Helena Almeida; Tabita M Maia; Luís Relvas; Ana C Oliveira; Cédric Rossi; François Girodon; Carlos Fernandez-Lago; Ascension Aguado-Diaz; Cristina Fraga; Ricardo M Costa; Ana L Araújo; João Silva; Helena Vitória; Natalina Miguel; Maria Pedro Silveira; Guillermo Martin-Nuñez; Maria Letícia Ribeiro
Journal:  Eur J Haematol       Date:  2013-08-20       Impact factor: 2.997

Review 8.  The complete evaluation of erythrocytosis: congenital and acquired.

Authors:  M M Patnaik; A Tefferi
Journal:  Leukemia       Date:  2009-03-19       Impact factor: 11.528

9.  Cardiovascular events and intensity of treatment in polycythemia vera.

Authors:  Roberto Marchioli; Guido Finazzi; Giorgina Specchia; Rossella Cacciola; Riccardo Cavazzina; Daniela Cilloni; Valerio De Stefano; Elena Elli; Alessandra Iurlo; Roberto Latagliata; Francesca Lunghi; Monia Lunghi; Rosa Maria Marfisi; Pellegrino Musto; Arianna Masciulli; Caterina Musolino; Nicola Cascavilla; Giovanni Quarta; Maria Luigia Randi; Davide Rapezzi; Marco Ruggeri; Elisa Rumi; Anna Rita Scortechini; Simone Santini; Marco Scarano; Sergio Siragusa; Antonio Spadea; Alessia Tieghi; Emanuele Angelucci; Giuseppe Visani; Alessandro Maria Vannucchi; Tiziano Barbui
Journal:  N Engl J Med       Date:  2012-12-08       Impact factor: 91.245

Review 10.  Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis.

Authors:  Victor R Gordeuk; Nigel S Key; Josef T Prchal
Journal:  Haematologica       Date:  2019-03-14       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.